HomeGuidesHeart Failure: Pathophysiology & Care
Back to Library
๐Ÿ”ฌ PathophysiologyAdvanced 19 min read

Heart Failure: Pathophysiology & Care

The pathophysiological cascade of heart failure, systolic vs. diastolic dysfunction, compensatory mechanisms, clinical manifestations, and evidence-based nursing management.

heart failureHFrEFHFpEFBNPcompensatory mechanismscardiomegaly

HF Pathophysiology

Heart failure = inability of the heart to pump sufficient blood to meet the body's metabolic demands. Primary injury (MI, cardiomyopathy, HTN, valvular disease) โ†’ decreased CO โ†’ neurohormonal activation (RAAS, SNS, ADH release) โ†’ vasoconstriction + fluid retention โ†’ increased preload + afterload โ†’ worsening cardiac remodeling. BNP (B-type natriuretic peptide) released by ventricular myocardium in response to stretch โ€” key diagnostic biomarker.

Types of Heart Failure

HFrEF (Heart Failure with Reduced Ejection Fraction): EF <40%; systolic dysfunction โ€” heart cannot contract adequately. HFpEF (preserved EF): EF โ‰ฅ50%; diastolic dysfunction โ€” heart cannot relax and fill adequately; increasingly common, especially in elderly and hypertensive women. Right HF: systemic congestion (JVD, ascites, peripheral edema, hepatomegaly). Left HF: pulmonary congestion (crackles, dyspnea, orthopnea, PND).

Compensatory Mechanisms

Short-term (initially helpful, long-term harmful): (1) Frank-Starling: increased preload โ†’ increased SV (limited). (2) Sympathetic activation: tachycardia + vasoconstriction. (3) Ventricular hypertrophy: thickened walls handle pressure better initially. (4) RAAS activation: sodium and water retention (fluid overload). (5) Ventricular remodeling: chamber dilation โ†’ further EF reduction. These mechanisms ultimately accelerate disease progression.

Clinical Manifestations

Left HF: dyspnea on exertion, orthopnea (use 2+ pillows), PND (waking at night breathless), crackles, S3 gallop, tachycardia, displaced PMI, fatigue. Right HF: JVD, peripheral pitting edema (ankles, sacrum in bedbound), ascites, hepatojugular reflux, anorexia/nausea (hepatic congestion), weight gain. NYHA Classification: I (no symptoms) โ†’ IV (symptoms at rest).

Nursing Management

Monitor: daily weights (same time, same scale, same clothing), I&O, edema, lung sounds, JVD, BNP, BMP. Medications: ACE-I/ARBs, beta-blockers, diuretics (furosemide), aldosterone antagonists (spironolactone), digoxin, SGLT2 inhibitors (empagliflozin) for HFrEF. Activity: balance rest and activity; cardiac rehab. Diet: sodium restriction (<2 g/day), fluid restriction as ordered. Position: HOB 30โ€“45ยฐ. Patient teaching: daily weights, symptoms to report (3-lb gain in 2 days).

Important Notes

  • Teach patients: weight gain of 2โ€“3 lbs in 1 day or 5 lbs in 1 week = notify healthcare provider immediately.
  • Spironolactone causes hyperkalemia โ€” monitor K+ closely, especially with ACE-I or ARBs.

Clinical Tips

  • S3 gallop = hallmark of HFrEF โ€” "lub-dub-da" best heard at apex with bell of stethoscope.
  • BNP >100 pg/mL is consistent with HF; >400 pg/mL strongly suggests HF exacerbation.

Summary

Heart failure is a progressive syndrome driven by neurohormonal activation and cardiac remodeling. Evidence-based nursing management includes medications, monitoring, diet, activity, and comprehensive patient education to prevent readmission.

Back to Library
base44
Edit with Base44